Glioblastoma multiform (GBM) is the most common and most aggressive primary brain tumor. The fibronectin receptor, α5 integrin is a pertinent novel therapeutic target. Despite numerous data showing that α5 integrin support tumor cell migration and invasion, it has been reported that α5 integrin can also limit cell dispersion by increasing cell-cell interaction. In this study, we showed that α5 integrin was involved in cell-cell interaction and gliomasphere formation. α5-mediated cell-cell cohesion limited cell dispersion from spheroids in fibronectin-poor microenvironment. However, in fibronectin-rich microenvironment, α5 integrin promoted cell dispersion. Ligand-occupied α5 integrin and fibronectin were distributed in fibril-like pattern at cell-cell junction of evading cells, forming cell-cell fibrillar adhesions. Activated focal adhesion kinase was not present in these adhesions but was progressively relocalized with α5 integrin as cell migrates away from the spheroids. α5 integrin function in GBM appears to be more complex than previously suspected. As GBM overexpressed fibronectin, it is most likely that in vivo, α5-mediated dissemination from the tumor mass overrides α5-mediated tumor cell cohesion. In this respect, α5-integrin antagonists may be useful to limit GBM invasion in brain parenchyma.
Glioblastoma multiform (GBM, grade IV astrocytoma) is the most frequent and most aggressive brain cancer. Despite surgical resection, radiotherapy and concomitant chemotherapy, median survival for a patient with high grade glioma does not exceed 15 months. GBM is characterized by a diffuse infiltration of the brain tissue by tumor cells. This highly invasive phenotype prevents complete surgical resection, limits the efficiency of radiotherapy and is a critical prognostic factor for primary brain tumors. The establishment of efficient therapies requires a better understanding of the infiltrative behavior of glioma cells and the development of new strategies targeting cell invasion [1, 2] . In situ, glioma cells individually infiltrate the brain tissue either by migrating along the blood vessels or by invading the parenchymal tissue [3, 4] . Invasion is modulated by regional expression of extracellular matrix (ECM) molecules [5, 6] . Some ECM proteins are overexpressed in human brain tumors and their upregulation correlates with disease progression and worse prognosis. Comparison of gene expression in invasive GBM versus non-invasive pilocytic astrocytoma using suppressive hybridization identified fibronectin (FN) as one of the most overexpressed gene in GBM [7] . FN accumulates around neovasculature [8, 9] and into tumor ECM as dense linear strands of assembled FN surrounding cancer cells [10] [11] [12] [13] . FN supports tumor growth [14] and is unequivocally capable of mediating glioma cell motility and promoting invasion [11, 13, 15] .
As primary receptors involved in cell-matrix adhesion, integrins bidirectionally link the ECM with the intracellular signaling network. They profoundly impact on tumor cell proliferation, survival and invasion, and trigger resistance to radio-and chemo-therapy [16] . In human brain, the FN receptor, α5β1 integrin, is expressed at significantly higher level in GBM than in adjacent normal tissue [17] . We [18, 19] and others [20] [21] [22] recently confirmed these data in larger cohorts of patients and showed that a high expression of α5β1 integrin is associated with a worse prognosis. Preclinical data support the ability of α5β1 integrin antagonists to disrupt integrin signaling pathways leading to inhibition of angiogenesis and/or tumor growth but also to sensitization toward therapies [23] . Depletion of α5 integrin increased p53 activity and sensitized cells to chemotherapeutic agents [19, 24] . Moreover α5β1 integrin antagonists facilitated chemotherapy-induced apoptosis in human glioma cells [24, 25] . Collectively, these data establish α5β1 integrin as a promising target in GBM. α5 integrin mediates fibronectin assembly, an essential process that regulates cell morphology, growth and motility [26] . On 2D cell culture, fibrillogenesis is initiated by α5 integrin in cell-substratum adhesion sites called fibrillar adhesion (FBs). FBs are functionally and molecularly distinct from the classical focal adhesion (FAs) as they did not contain activated FAK (focal adhesion kinase) or other FAs proteins such as paxillin or vinculin [27, 28] . Drug-mediated inhibition of FN fibrillogenesis sensitizes glioma cells to chemotherapy in vitro and in vivo [12] . Fibrillar FN/α5 axis may thus play a pivotal role in glioma resistance to therapy and invasion.
Using single cell tracking assays, we showed that expression of α5 integrin in U87MG cells increased cell migration speed, which could be inhibited by the use of specific non-peptidic antagonists of α5β1 integrin [29, 30] . However, other reports showed that α5β1 and fibrillary FN can promote cell/cell cohesion in various tissue [13, [31] [32] [33] and may impair glioma cell dispersion [32] . This observation point out a potential anti-invasive role for α5β1 and cellmediated FN assembly. This may raise an important issue concerning the development of anti-invasive therapeutic strategies that target α5β1 integrin.
In the present work, we showed that α5-mediated cell-cell interaction can counteract cell dissemination only if fibronectin is absent from tumor cell microenvironment. We observed that in cells collectively emerging from the spheroid, α5 integrin delineated plasma membrane in a fibrillar-like pattern and is associated with a dense FN fibril network. Importantly, activated FAK (pFAKtyr397) was not recruited by α5 integrin in these cell-cell fibrillar adhesions. As cells moved away from the spheroids, α5 became strictly engaged in cell-substratum adhesion sites, where it progressively recruited pFAK-tyr397. In conclusion, our data indicate that in GBM α5 integrin may have different function and that glioma cell invasion is regulated by the balance between α5-mediated cellcell and cell-substratum interaction.
Material and methods

Reagents
Function blocking antibodies directed against α5 integrin, clone IIA1 was from BD Biosciences and against αv integrin, clone 69.6.5 was produced and purified as previously described [34] . Following antibodies were used for confocal microscopy. Conformation dependent LIBS anti-α5 antibody clone SNAKA-51 was from Millipore. Phycoerythrin-conjugated anti-α5 antibody (clone SAM-1) was from BioLegend. Anti-β1 antibody clone TS2/16 was produced from the hybridoma cell line TS2/16.2.1 (HB-243, ATCC) and purified on protein-G-sepharose column (Pierce). Anti-αv antibody, clone PLW7, was from Santa Cruz Biotechnology, anti-fibronectin antibody, clone 10, was from BD Biosciences, anti-pFAK-tyr397, clone 141-9 from Life Technologies. Fluorescently labeled secondary antibodies were purchased from Invitrogen (Alexa Fluor −488; −546; −647). Dapi was purchased from Santa Cruz Biotechnology. Human fibronectin stabilized solution was purified as described in Reference 35. Cell culture medium and reagents were from Lonza. All other reagents were of molecular biology quality.
Cell culture
The human glioblastoma cell line U87MG was obtained from ATCC. U87MG cells were maintained in Eagle's minimum essential medium (EMEM) supplemented with 10% fetal bovine serum (FBS), 1% L-glutamine, 1% sodium pyruvate and 1% nonessential amino-acid, in a 37°C humidified incubator with 5% CO2. U87MG cells were transfected with plasmid encoding α5 cDNA or specific shRNA targeting α5mRNA as described [19] , except that after selection with antibiotics, stably transfected cells were mass-selected by two steps of cell sorting (FACSAria™ II, BD Bioscience) using PE-conjugated SAM-1 antibody. We selected cells expressing various amount of α5 integrin. Cell surface expression of β1 and αv subunits were controlled by flow cytometry analysis (10,000 cells analyzed for each condition) using TS2/16 and 69-6-5 monoclonal antibodies respectively. α5 and β1ntegrin expression levels were further analyzed by immunoblot using IIa1 and TS2/16 monoclonal antibodies as described [19] . In the present study we used U87 cells transfected with pcDNA3.1α5 as high α5 expressing cells (U87α5+) and U87 cells expressing α5-shRNA as low α5 expressing (U87α5−). LN229 and LN443 cells were cultured as described in Reference 24. LN229 cells were transfected as described for U87 cells. LN229 clonal populations were obtained by limited dilution and clones expressing various amount of α5 integrin were selected.
Proliferation assay
Cells were plated (1000 cells/well) onto a 96-well plate in EMEM supplemented with 10% FBS. At indicated times, cell viability was determined using a tetrazolium compound [3-(4,5-dimethyl-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS assay -CellTiter 96 AQueous One Solution Cell proliferation assay from Promega).
Spheroid formation
Six grams of methylcellulose was dissolved in 250 mL of EMEM and heated at 60°C for 1 h. The solution was then kept at 4°C under agitation for 18 hours. The solution was cleared by centrifugation (5000 g, 2 h). Single cell suspension was generated from trypsinized monolayers and diluted at the desired cell density. Cell suspension was mixed in EMEM/10%FBS containing 20% of methylcellulose. All the spheroids were made with 2000 cells. Cell spheroids were formed by hanging drop methods (25 μL, 2000 cells per sphere) or on a U-bottom 96 well plate (Greiner Cellstar U-bottom culture plate) (100 μL, 2000 cells).
Spheroid organization
Spherical organization of 20 spheroids/condition was followed regularly from 0 to 48 hours on phase-contrast images (EVOS xl Core, 20× magnification). Circularity measurements (roundness) were measured using shape descriptors of ImageJ software [36] . When indicated function blocking anti-integrin antibodies (anti-α5, clone IIa1; anti-αv, clone 69.6.5) were added at 10 μg/mL in the cell suspension.
Spheroid migration assays
Plastic dishes were coated with poly-L-lysine (10 μg/mL) or fibronectin (indicated concentration) in PBS solution for 2 h at 37°C. Two-day old spheroids were allowed to adhere to 24-well plates in complete medium (EMEM, 10% FBS). Eighteen hours later, cells were fixed with paraformaldehyde 3.7% (Electron Microscopy Sciences) and stained with DAPI. Phase-contrast images (EVOS xl Core, 5× magnification) were acquired. Cell number was quantified with a home-made macro using ImageJ software.
Confocal microscopy and image analysis
Coverslips were coated with fibronectin (10 μg/mL in PBS). Two-day old spheroids were seeded in complete medium for 18 hours. Cells were then fixed in 3.7% paraformaldehyde, and permeabilized with 0.1% Triton-X100. After a 1 hour blocking step using TBS-BSA 3% solution, cells were incubated with primary antibodies O/N at 4°C (2 μg/mL each in TBS-BSA 3%). Cells were incubated with appropriate secondary antibodies (1 μg/mL in TBS-BSA 3%) and DAPI for 1 hour. Spheroids were mounted on microscope slides using Permafluor Aqueous Mounting Medium (Fisher). Images were acquired using a confocal microscope (LEICA TCS SPE II, 60× magnification oil-immersion). Feret's diameter used as adhesion size criteria were quantified using an ImageJ plugin developed in the lab. Pearson correlation coefficient was calculated using JACop plugin ImageJ software [37] . Suspended spheroids were fixed with 3.7% paraformaldehyde, and permeabilized with 0.1% Triton-X100 for 5 min. Saturation and immunolabeling were performed on U-bottom 96 well plates.
Immunostaining on patient-derived xenograft
A patient-derived integrin α5 expressing glioblastoma xenograft was selected for in vivo analysis as described in Reference 19. Briefly, formalin-fixed paraffinembedded xenograft was prepared as previously described [19] and 4 μm sections were deparaffinized, rehydrated and subjected to unmask the antigen protocol using Dako retrieval solution pH9. Next, blocking buffer (5% Goat serum, 0.1% Tween-20, PBS) was applied for 1 hour at room temperature. Integrin α5 and fibronectin were labeled with rabbit antibody directed against α5 integrin cytoplasmic tail (AB1928, Millipore) and mouse anti-fibronectin Alexa Fluor® 488 (FN-3, eBioscience), respectively (overnight incubation at 4°C). After washing in PBS-Tween 0.1%, tissue sections were incubated for 1 hour with appropriate secondary antibody (goat antirabbit IgG Alexa Fluor® 647, Invitrogen). Nuclei were counterstained with DAPI and coverslips were mounted onto tissue section using Permafluor Aqueous Mounting Medium (Fisher). Images were acquired using a confocal microscope as previously described.
Dual wide field/TIRF imaging
Dual Wide field/TIRF images were acquired using an iMIC microscope (Till Photonics) equipped with a Cobolt Dual Calypso Laser 491/532 nm, a monochromator Polychrome V and an Olympus 60× TIRFM (1.45 NA) objective. A multiband filter set was used for excitation of DAPI, Alexa fluor 491 and Alexa fluor 568. Wide field and TIRF images were recorded on an EMCCD camera (Andor Technology) and analyzed using ImageJ software.
Statistical analysis
Data are reported as mean ± S.E.M. unless otherwise stated. Statistical analysis between samples was done by one way analysis of the variance (ANOVA) followed by Bonferroni post-test with the GraphPad Prism program. Significance level is controlled by 95% confidence interval.
Results
α5 integrin and FN are involved in U87MG cell cohesion
Multicellular tumor spheroid is an in vitro model used in numerous studies to mimic micro-tumors [38] . FN assembly can promote cell-cell adhesion and foster spheroid formation in various cell types [39, 40] including U87MG glioma cells [13, 32] . In CHO cells, this process involves the α5β1 integrin [31, 41] . We seek to assess the role of the FN receptor α5β1 in glioma cell-cell adhesion. U87MG cells express α5β1 integrin endogenously and were manipulated to increase or decrease the expression of the α5 integrin subunit. Cells were sorted for various expressions of α5 integrin. α5, β1 and αv integrin expression was controlled by flow cytometry analysis (Fig. 1A , left panel). α5 and β1 expression was further confirmed by immunoblot (Fig. 1A , right panel). For this study we consistently used the cell expressing the highest (U87α5+) and lowest (U87α5−) level of α5 integrin.
Under conventional culture condition, upon reaching high cell density, α5 integrin depletion significantly decreased the spontaneous formation of multicellular organoid (Fig. 1B) . After 3 days of culture, cell growth was similar for both cells indicating that the absence of spheroids in U87α5− cell culture was not due to a decrease in cell density (Fig. 1B) . We next challenged U87α5+ and U87α5− cells in spheroid formation from suspended cells. We monitored the kinetics of spheroid formation, i.e., spheroid area and spherical form (roundness) to assess the role of α5 integrin in cell aggregation and tissue compaction. As shown in Fig. 1C , initial cell aggregation (after 6 hours of incubation) was not dependent on α5 expression level. At 24 hours, U87α5+ cells increased their compaction and adopted a regular circular shape whereas α5-depleted cells presented a delayed cell compaction and spheroid formation. This difference is no more observed after 48 hours. α5 integrin involvement in U87 spheroid formation was further confirmed by antibody-mediated. As a control, function inhibition of αv integrin (another fibronectin receptor) had no impact on spheroid formation (Fig. 1D) . Confocal microscopy was next used to reveal the distribution of α5 integrin, β1 integrin and FN on 2-day-old spheroids. For staining α5 integrin, we used a monoclonal antibody (clone Snaka51) that recognizes a LIBS (ligand-induced binding site) epitope on the calf1/calf2 domain of α5 integrin and that is a reporter of α5β1 integrin activation and binding to FN [42] . Confocal images of U87α5+ spheroids clearly show the localization of the ligandoccupied α5 integrin at the cell/cell contact and in vesicular-like intracellular structures (Fig. 2) . Low-level α5 expressing cells present a faint staining, with some remaining cell surface labeling in only a fraction of the cells. Anti-β1 integrin antibody stained the cell membrane similarly in both cell lines. FN labeling revealed a dense fibrillar network of assembled FN between U87α5+ cells. FN fibrillogenesis was α5β1-dependent as depicted by FNimmunolabeling in U87α5− spheroids. Accordingly, immunolabeling of FN in LN229 glioma spheroids revealed the presence of a dense fibrillary network on α5 expressing cells. As shown in U87 cells, α5-depletion on LN229 cells decreased FN assembly (Fig. S1) . Consistent with previous published data [13, 31, 39, 41] , our results highlighted that α5β1 integrin mediates FN fibrillogenesis in tumor sphere and can promote glioma cell-cell adhesion via α5β1/FNmediated bridges.
Balance between α5-mediated cell-cell and cell-substratum adhesion directs U87 evasion FN-mediated cell/cell cohesion has been associated with a decrease in cell dispersion from prostate tumor spheroids, suggesting that α5β1 may have anti-invasive function [32] . To confirm this observation on glioma cells, we examined the effect of α5 integrin expression on spheroid evasion, a model of collective migration. In the first set of experiments, U87 spheroids were deposited onto poly-L-lysine coated plates. Phase contrast images (Fig. 3A) and image analysis show that α5 integrin depletion or its functional inhibition significantly increased the number of evading cells (Fig. 3B ) but had no effect on the mean distance of migration from the spheroids (Fig. 3C) . Similar data were obtained using clonal population of LN229 GBM cells genetically manipulated to express various amount of α5 integrin (Fig. S1 ). Inhibition of αv integrin suppressed U87 cell evasion and migration in all experimental conditions. Since αv inhibition had no impact on spheroid formation (Fig. 1D) , these data suggested that migration on poly-Llysine did not require α5 integrin but was αv-dependent. The nonreceptor tyrosine kinase FAK (focal adhesion kinase) is an essential marker of focal adhesions and is phosphorylated on tyr397 upon its recruitment by integrins [43] . After immunolabeling the migrating cells, confocal images show the localization of αv integrin in pFAK-tyr397 positive focal adhesion (FA), supporting for a functional role of this integrin in U87α5− cell dispersion on poly-L-lysine (Fig. S2) . Taken together, these data are in line with those from Reference 32, suggesting that α5 integrin/FN mediated cell-cell adhesion may impede cell dispersion from tumor mass.
However, cell dispersion from multicellular aggregates is regulated by opposite forces produced by cell-cell adhesion and ECM mediated cell migration [44, 45] . In such a case, the presence of FN in the surrounding microenvironment would engage α5β1 integrin in cell-substratum interaction and challenge FN-mediated cellcell adhesion. To test this hypothesis, we examined cell dispersion of U87 spheres plated on wells coated with increasing amounts of FN. Phase-contrast images (Fig. 4A ) and image quantification ( Fig. 4B and C) showed that U87α5+ cell dissemination was dependent on FN concentration. By contrast, evasion and migration of U87α5− cells were not stimulated by the presence of FN in spheroid microenvironment. To assess the integrin involved in cell evasion and migration from the spheroid, we used function blocking antibodies on spheroid plated on FN-rich substratum. In this case, the number of U87α5+ cells evading cells and their distance of migration were α5β1-dependent and did not require functional αv (Fig. 4D, left panels) . By contrast, for U87α5− cells, the number of evaded cells was inhibited by anti-αv antibody and to a lesser extent by anti-α5 antibody, and their distance of migration was strictly dependent of αv integrin and not of the α5 integrin (Fig. 4D, right panels) . Involvement of αv integrin in U87α5− cell migration was further confirmed by immunostaining of αv integrin and pFAK-tyr397. Our data clearly show the presence of mature FAs containing both αv integrin and pFAK-tyr397 on U87α5− cells that migrated at great distances away from spheroids (Fig. S2) . Altogether, these results highlight that changes in FN concentration in the tumor sphere microenvironment regulate the balance between α5 integrin-mediated cell-cell and cell-substratum adhesion, and as a consequence, U87 cell dissemination.
Remodeling of α5 integrin adhesion during cell evasion from spheroid
To gain insight into the role of α5β1 in cell-cell interaction and during cell evasion from tumor organoid, we examined by confocal microscopy, the distribution of ligand-occupied α5 integrin and FN. In the first series of images (Fig. 5A) , focal planes were selected at a distance of 5 μm above the coverslips at the margin of the spheroid (indicated by the dashed lines in the figures). As U87α5+ cells emerged from the spheroid, α5 integrin depicted a pattern with thin and long fibrils. 3D reconstruction of whole z-stacks showed that ligand-occupied α5 is clearly around the cells (Fig. S3) . Moreover, a dense fibrillar network of assembled FN was clearly visible. In α5-depleted glioma cells evaded from the spheroid did not form any FN network (Fig. 5A ). To confirm these results, we used LN443, another GBM cell line expressing a high level of α5 integrin (Fig. S2) . In LN443 cells, activated-α5 integrin depicted a similar pattern to that of U87α5+ cells (Figs. S4 and S5) . We also observed a dense network of assembled FN surrounding emerging LN433 cells (Figs. S6 and S7). To assess the presence of fibrillogenesis in vivo, FN and α5 integrin distribution were examined by confocal immunofluorescence on paraffin embedded tissue sections of human tumor xenografts. Interestingly, we found numerous areas presenting dense FN fibrillary network and strong α5 immunoreactivity (Fig. S8) , confirming the relevance of fibrillary FN in GBM models. These observations indicated that glioma cells evaded collectively from the spheroid. During this process, α5 integrin maintained cellcell interaction in fibrillar-like adhesions. To the best of our knowledge, this is the first description of this kind of adhesive structure.
To examine the organization of α5 integrin and of its ligand at the cell-substratum level, a second series of confocal images was taken on the same microscopic fields, but at a focal plane corresponding to the cell-substratum interface (Fig. 5B) . Matrix-bound α5 integrin exhibited a pattern clearly distinguishable to that of cellcell fibrillar adhesions. The integrin was distributed in thin dots with some elongated labeling resembling small fibrils (arrow heads). These integrin adhesion sites were morphologically distinct from classical focal adhesions (FAs, Fig. 6C ). The presence of thin and short FN fibrils (arrow heads) indicated a reduced FN assembly at the substratum level compared to the one observed at cell-cell interaction level. In our experimental settings, coated FN was also immunodetected. The loss of immunoreactivity under the spheroid and under the evading cells likely reflected an intense matrix remodeling. In U87α5− cells, FN assembly was further decreased and FN remodeling was less pronounced. Together, these experiments described that glioma cells may maintain contact with their neighbor during collective evasion using α5 integrin and assembled FN.
α5 integrin does not colocalize with pFAK-tyr397 in cell-cell fibrillar adhesion
By confocal microscopy, we examined α5 and pFAK-tyr397 colocalization on U87α5+ and LN433 glioma cells. Surprisingly, in cells that collectively emerged from the spheroid, pFAK-tyr397 was distributed as punctate intracellular clusters (Figs. 6A and S4A ) of size smaller than the classical FAs ( Fig. 6C and D) . Image quantification showed that in U87 cells, pFAK-tyr397 did not colocalize with FN-bound α5 integrin (Fig. 6E) . The absence of colocalization between pFAK-tyr397 and α5 integrin at cell-cell junction was also observed on confocal images of U87α5+ suspended spheroids (Fig. S9) . Altogether, these data indicate that pFAK-tyr397 was not associated with cell-cell fibrillary adhesion. At the substratum level of glioma cells close to spheroids (Figs. 6B and S4B ), pFAK-tyr397 was also found in small punctate cluster (Fig. 6D ) that did not colocalize with α5 integrin (Fig. 6E) . Classical labeling of FAs and strong colocalization between α5 integrin and pFAK-tyr397 were found in cells that had migrated to long distances from the tumor sphere (Figs. 6C, E and S4, arrow heads). α5 integrin was also detected in thin classical fibrillar adhesions characterized by the absence of pFAKtyr397 (Figs. 6C and S4C, arrows) .
The previous experiments suggest that classical FAs were progressively formed as glioma cells migrated away from the spheroids. To further confirm this observation, we examined α5 integrin adhesion reorganization at the substratum level using total internal reflection microscopy (TIRF). Dual color wide field TIRF experiments confirmed the presence of a punctate pFAK-tyr397 staining in cells localized beneath and in close proximity of the spheroid, suggesting that they were not able to assemble mature FAs. Integrin α5 was not found with these punctuate structures but was rather associated with cell-cell contacts and/or fibronectin fibrils as suggested by the elongated form of the staining (Fig. 7A and B) . On the other hand, when cells migrated away from the spheroid, colocalization of integrin α5 and pFAK-tyr397 at focal complexes and focal adhesions could be observed (Fig. 7C) . Our data showed that cell-cell fibrillar adhesion did not contain activated FAK and that classical α5-containing FAs are progressively formed during the process of cell migration. 
and β1 expression level on the U87 cell lines: lane 1, U87α5+; lane2, U87pcDNA, lane3, U87α5−; lane4, U87shCtrl. (B) Phase contrast images of U87 cells cultured for 4 days under conventional conditions. Scale bar: 200 μm. The number of cell clusters per field was manually counted. Data presented are the mean ± s.e.m. of 3 different experiments (4 fields/experiments). U87 cells were cultured for 3 days on plastic dishes and cell growth was monitored as described in Material and methods. (C) Left panel -phase contrast images of U87 cell spheroid for the indicated period of time in non-adherent U-shaped wells (2000 cells/well). Right panel -morphological parameters (area and roundness) of each spheroid were measured using ImageJ sofware. (D) Spheroids were formed for 18 h in the presence of irrelevant IgG or function-blocking antibodies targeting α5 or αv integrins (10 μg/mL each) and spheroid roundness was monitored. Data are the mean ± s.e.m of 15-20 spheroids from 3 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. Fig. 2 . Distribution of α5, β1 integrins and fibronectin in U87 cell spheroids. Suspended spheroids were immunolabeled as described in Material and methods. Confocal images were taken at an optical section between 10 μm and 20 μm above the base of the spheroid. Note the increase amount of fibrils in U87α5+ cells. Nuclei were stained with DAPI. Bar = 20 μm.
Discussion
Highly efficient infiltration in the surrounding brain parenchyma is a hallmark of glioblastoma cells and a major cause of therapy failure. A better understanding of GBM cell invasive behavior is urgently needed to improve therapeutic approaches to fight these tumors [2] . In the present work, we intended to clarify the function of α5 integrin, the fibronectin receptor, in GBM spheroid formation and in cell dispersion. We found that ligand-occupied α5 integrin can be localized in fibrillar adhesion at cell-cell interaction. These results exemplify the molecular and morphological diversity and the plasticity of α5 adhesions engaged both in cellcell and cell-substratum interactions. We showed that cell evasion from tumor sphere is regulated by a balance between α5-mediated cell-cell and cell-substratum interactions. In clinical situation, GBM frequently overexpressed FN that is found in fibrillar deposit in the tumor [12] . High level of FN expression will thus promote α5β1-mediated glioma cell dissemination from the tumor mass. In such case patients would benefit from anti-α5 integrin therapy.
Multicellular tumor spheroids are three dimensional (3D) architecture that mimic avascular tumor areas comprising the establishment of diffusion gradients, reduced proliferation rates and increased drug resistance. They are increasingly used as an improvement of conventional 2D culture systems as they offer 3D in vivo-like environment as well as cell-ECM and cell-cell interactions. Spheroid formation from a cell suspension is a multistep process that required cell aggregation and tension force mediated cell compaction [46] . The present work illustrated that α5β1 and cell-mediated FN fibrillogenesis play a pivotal role in glioma spheroid formation. Time course experiments indicated that α5β1 expression level has no impact on the early phase of spheroid formation. This is in line with other studies [47, 48] showing that integrins are not involved in cell aggregation but rather promote the condensation phase of the spheroid formation. In agreement with previous published data [13, [31] [32] [33] 40, 41, 49] , it is likely that, in tumor cell aggregates, α5-mediated cell tension and contractility promotes FN assembly and cell-cell interaction.
An important observation of our work is that during their collective evasion from tumor sphere, glioma cells maintained contacts with their neighbor using cell-cell fibrillar adhesions. In line with previous studies comparing FN fibrillogenesis in 2D and 3D cell cultures [50] [51] [52] , we observed that fibrillar FN networks were much more developed at cell-cell interaction than at cell-substratum level. In our experimental model, α5 integrin relocalized at cell substratum adhesion sites and progressively formed mature FAs as cells migrated at distance from the spheroid, requiring FN matrix remodeling and turnover. It has been shown that RhoA signaling pathway and inverted formin 2 promote fibrillary adhesion and FN matrix assembly [53] [54] [55] [56] [57] . Conversely, the caveolin-1 and RAS-RAF signaling pathway inhibit FN fibrillogenesis [52, 58] . FN fibrils turnover is also regulated by extracellular proteins such as transglutaminase 2 or the membrane type matrix metalloproteinase 1 [12, 59, 60] . Future experiments will help to decipher molecular pathways involved in cell-cell fibrillar adhesion turnover during glioma cell dissemination. In this context, cell dispersion from spheroids represents a useful model to study the dynamics of α5 integrin adhesion sites and fibrillar FN remodeling that may take place during glioma cell invasion in vivo.
Our data indicate that α5 integrin can trigger cell-cell interaction and FN fibrillogenesis independently of pFAK-tyr397 recruitment. At cell-substratum level, pFAK-tyr397 was poorly associated with ligand-bound α5 integrin on cells close to the spheroid. pFAK-tyr397/integrin association was progressively detectable on migrating cells. This observation suggests that α5 integrin engagement at cell-cell contact may regulate cell-substratum interaction by inhibiting pFAK-tyr397 recruitment at the plasma membrane and therefore FAs formation and maturation. In glioblastoma, α5β1 integrin may thus not always be associated with pFAK-tyr397 and their interaction may be finely regulated by the balance between cell-cell and cell-substratum interactions. For instance, in situ analysis revealed that in glioblastoma, co-expression of β1 integrin and pFAK-tyr397 was detected in morphologically defined regions such as perivascular or tumor infiltration zones and not in the tumor mass [61] .
In the present work, we described for the first time cell-cell fibrillar adhesions as pFAK-tyr397-independent α5 adhesion sites involved in glioma cell-cell interactions. A recent study demonstrated that α5 integrin can foster cell-cell adhesion by an alternative mechanism, involving direct interaction between inactive integrins expressed by adjacent cells [62] . In light of these new data, it appears that α5 integrin function is not restricted to cell-substratum adhesion and that its involvement in glioma and in other solid cancers progression may deserve a reevaluation. We and others have shown that α5 integrins play a critical role in glioma resistance to radioand chemo-therapy. It will be important in the future to characterize the composition, the regulation and the function of cellcell fibrillar adhesions in order to better assess its involvement in glioma progression and resistance to therapy. In this context, our experimental model will be useful for the design of new effective strategies for fighting GBM. 595  596  597  598  599  600  601  602  603  604  605  606  607  608  609  610  611  612  613  614  615  616  617  618  619  620  621  622  623  624  625  626  627  628  629  630  631  632  633  634  635  636  637  638  639  640  641  642  643  644  645  646  647  648  649  650  651  652  653  654  655  656  657  658  659  660  661  662  663  664  665  666  667  668  669  670  671  672  673  674  675  676  677  678  679 
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